| Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E2 regulates the migratory capacity of specific DC subsets T Luft, M Jefford, P Luetjens, T Toy, H Hochrein, KA Masterman, ... Blood, The Journal of the American Society of Hematology 100 (4), 1362-1372, 2002 | 480 | 2002 |
| Conservation and divergence in Toll-like receptor 4-regulated gene expression in primary human versus mouse macrophages K Schroder, KM Irvine, MS Taylor, NJ Bokil, KA Le Cao, KA Masterman, ... Proceedings of the National Academy of Sciences 109 (16), E944-E953, 2012 | 331 | 2012 |
| IFN‐α enhances CD40 ligand‐mediated activation of immature monocyte‐derived dendritic cells T Luft, P Luetjens, H Hochrein, T Toy, KA Masterman, M Rizkalla, ... International immunology 14 (4), 367-380, 2002 | 178 | 2002 |
| IL-1β enhances CD40 ligand-mediated cytokine secretion by human dendritic cells (DC): a mechanism for T cell-independent DC activation T Luft, M Jefford, P Luetjens, H Hochrein, KA Masterman, C Maliszewski, ... The Journal of Immunology 168 (2), 713-722, 2002 | 160 | 2002 |
| Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuli M Jefford, M Schnurr, T Toy, KA Masterman, A Shin, T Beecroft, TY Tai, ... Blood 102 (5), 1753-1763, 2003 | 157 | 2003 |
| The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand M Shackleton, ID Davis, W Hopkins, H Jackson, N Dimopoulos, T Tai, ... Cancer Immunity 4 (1), 2004 | 143 | 2004 |
| Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant Q Chen, H Jackson, P Parente, T Luke, M Rizkalla, TY Tai, HC Zhu, ... Proceedings of the National Academy of Sciences 101 (25), 9363-9368, 2004 | 118 | 2004 |
| NY-ESO-1 Protein Formulated in ISCOMATRIX Adjuvant Is a Potent Anticancer Vaccine Inducing Both Humoral and CD8+ T-Cell-Mediated Immunity and Protection against … E Maraskovsky, S Sjölander, DP Drane, M Schnurr, TTT Le, L Mateo, ... Clinical cancer research 10 (8), 2879-2890, 2004 | 117 | 2004 |
| Cross‐priming of CD8+ T cells by viral and tumor antigens is a robust phenomenon W Chen, KA Masterman, S Basta, SM Mansour Haeryfar, N Dimopoulos, ... European journal of immunology 34 (1), 194-199, 2004 | 115 | 2004 |
| Reversal in the immunodominance hierarchy in secondary CD8+ T cell responses to influenza A virus: roles for cross-presentation and lysis-independent immunodomination W Chen, K Pang, KA Masterman, G Kennedy, S Basta, N Dimopoulos, ... The Journal of Immunology 173 (8), 5021-5027, 2004 | 108 | 2004 |
| Characterization of antigen-specific CD8+ T lymphocyte responses in skin and peripheral blood following intradermal peptide vaccination Q Chen, H Jackson, M Shackleton, P Parente, W Hopkins, S Sturrock, ... Cancer Immunity 5 (1), 2005 | 42 | 2005 |
| Human CD141+ dendritic cells (cDC1) are impaired in patients with advanced melanoma but can be targeted to enhance anti-PD-1 in a humanized mouse model YS Lee, LJ O'Brien, CM Walpole, FE Pearson, IM Leal-Rojas, ... Journal for immunotherapy of cancer 9 (3), 2021 | 34 | 2021 |
| Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141+ dendritic cells to activate naïve and memory NY-ESO-1-specific CD8+ T cells KA Masterman, OL Haigh, KM Tullett, IM Leal-Rojas, C Walpole, ... Journal for immunotherapy of cancer 8 (2), 2020 | 31 | 2020 |
| Human CLEC9A antibodies deliver Wilms' tumor 1 (WT1) antigen to CD141+ dendritic cells to activate naïve and memory WT1‐specific CD8+ T cells FE Pearson, KM Tullett, IM Leal‐Rojas, OL Haigh, KA Masterman, ... Clinical & translational immunology 9 (6), e1141, 2020 | 28 | 2020 |
| Development of an automated, high-throughput bactericidal assay that measures cellular respiration as a survival readout for Neisseria meningitidis PA Mak, GF Santos, KA Masterman, J Janes, B Wacknov, K Vienken, ... Clinical and Vaccine Immunology 18 (8), 1252-1260, 2011 | 28 | 2011 |
| Characterization of the peptide-binding specificity of the chimpanzee class I alleles A* 0301 and A* 0401 using a combinatorial peptide library J Sidney, B Peters, C Moore, TJ Pencille, S Ngo, KA Masterman, S Asabe, ... Immunogenetics 59, 745-751, 2007 | 23 | 2007 |
| Discordance in STING-induced activation and cell death between mouse and human dendritic cell populations ES Pang, G Daraj, KR Balka, D De Nardo, C Macri, H Hochrein, ... Frontiers in Immunology 13, 794776, 2022 | 9 | 2022 |
| A reliable method for enrichment of neutrophils from peripheral blood in barramundi (Lates calcarifer) KA Masterman, AC Barnes Fish & Shellfish Immunology 58, 174-176, 2016 | 3 | 2016 |
| Abstract B125: Targeting human CD141+ DC using CLEC9A antibodies for cancer immunotherapy K Radford, F Pearson, KA Masterman, K Tullett, O Haigh, C Walpole, ... Cancer Immunology Research 7 (2_Supplement), B125-B125, 2019 | 2 | 2019 |
| Immune defence mechanisms of barramundi (Lates calcarifer) peripheral blood against Streptococci KA Masterman | 2 | 2016 |
